NanoCARE network, coordinated by NanoMedMol
The Nanomedicine network for the diagnosis and treatment of diseases with large social impact: cancer, atherosclerosis, infections has been accepted by the Spanish Science Agency.
NanoMedMol coordinates this network with groups all over Spain to manage the development of new nanomedicines against diseases like paediatric cancer, atherosclerosis and multi-resistant bacteria.
Our new article in ACS Omega
3 nm iron oxide nanoparticles doped with Cu for enhanced positive contrast in MRI
Feb 6th 2019
Our new article in Nanomedicine: Nanotechnology, Biology and Medicine:
Bioorthogonal chemistry for the pretargeted imaging of atherosclerosis
Jan 16th 2019
Special Issue “Magnetic Nanoparticles in Biomedical Applications” in the journal Materials
Potential topics include but are not limited to the following:
Magnetic nanoparticles as MRI probes (T1 and/or T2)
Magnetic nanoparticles as in vitro sensors
Magnetic particle imaging
Magnetic nanoparticles in nuclear imaging techniques
New synthetic methods
Bioconjugation of magnetic nanoparticles for bioimaging
Protein corona and magnetic nanoparticles
Dr. Fernando Herranz
Dr. Juan Pellico
October 8th 2018
We are looking for candidates to ask for one FPU 2018 grant.
Project on Nanomedicine and Molecular Imaging for the diagnosis of Cardiovascular diseases. We are looking for chemists, pharmacists and biomedical engineers
Check here the conditions: https://www.mecd.gob.es/servicios-al-ciudadano-mecd/catalogo/general/educacion/998758/ficha/998758-2018.html
Contact us for more information, here: email@example.com
New paper in collaboration with H. Groult (former PhD student in the lab) now at Université de la Rochelle, A. Fernández-Mayoralas from IQOG-CSIC, L. Romero from Instituto Cajal-CSIC and Jesús Ruiz-Cabello from CIC biomaGUNE.
Micellar Iron Oxide Nanoparticles Coated with Anti-Tumor Glycosides
New review from our group: Molecular Imaging with 68Ga Radio-Nanomaterials: Shedding Light on Nanoparticles just published on Applied Sciences.